AvePoint (AVPT) director Jeff Epstein receives 16,493 RSU share grant

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Epstein Jeff reported acquisition or exercise transactions in this Form 4 filing.

AvePoint, Inc. director Jeff Epstein received a grant of 16,493 shares of common stock in the form of restricted stock units (RSUs) valued at $11.52 per share. This is a compensation-related award, not an open-market purchase.

According to the terms, 100% of these RSUs will vest on June 1, 2027, conditional on his continued service with the company through that date. After this grant, Epstein directly holds a total of 1,184,128 shares of AvePoint common stock, including RSUs.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Epstein Jeff

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	16,493	$11.52	$190K

Holdings After Transaction: Common Stock — 1,184,128 shares (Direct, null)

Footnotes (1)

This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. 100% of the RSUs will vest on June 1, 2027, following the Reporting Person's continued service with the Issuer as of that vesting date.

Key Figures

RSU grant size: 16,493 shares Grant value per share: $11.52 per share Total holdings after grant: 1,184,128 shares +1 more

4 metrics

RSU grant size 16,493 shares Restricted stock units granted to director Jeff Epstein

Grant value per share $11.52 per share Per-share value of AvePoint common stock underlying RSUs

Total holdings after grant 1,184,128 shares Direct AvePoint holdings by Jeff Epstein following the award

RSU vesting date June 1, 2027 100% of RSUs vest on this date with continued service

Key Terms

restricted stock units, RSU, 2021 Equity Incentive Plan

3 terms

restricted stock units financial

"This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU")"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSU financial

"Each RSU represents the contingent right to receive, upon vesting of the RSU, one share"

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

2021 Equity Incentive Plan financial

"RSU granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/03/2026 - 06:19 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Epstein Jeff

(Last)

(First)

(Middle)

C/O AVEPOINT, INC.

525 WASHINGTON BOULEVARD, SUITE 1400

(Street)

JERSEY CITY

NEW JERSEY

07310

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AvePoint, Inc. [ AVPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock⁽¹⁾	06/01/2026		A		16,493⁽²⁾	A	$11.52	1,184,128	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.

2. 100% of the RSUs will vest on June 1, 2027, following the Reporting Person's continued service with the Issuer as of that vesting date.

	/s/ Brian Michael Brown, Attorney-in-Fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did AvePoint (AVPT) director Jeff Epstein report?

Jeff Epstein reported receiving 16,493 AvePoint RSUs as a compensation grant. The award represents common stock valued at $11.52 per share and increases his total direct holdings to 1,184,128 shares, including restricted stock units.

Was Jeff Epstein’s AvePoint (AVPT) Form 4 a stock purchase or a grant?

The Form 4 shows a grant, not an open-market purchase. Epstein acquired 16,493 restricted stock units as compensation, each representing one share of AvePoint common stock upon vesting, rather than buying shares in the market.

What are the vesting terms of Jeff Epstein’s new AvePoint (AVPT) RSUs?

All of the 16,493 RSUs will vest on June 1, 2027. Vesting is contingent on Epstein’s continued service with AvePoint through that date, meaning he must remain in his role for the award to fully convert into shares.

How many AvePoint (AVPT) shares does Jeff Epstein hold after this Form 4 transaction?

After the grant, Jeff Epstein directly holds 1,184,128 shares of AvePoint common stock, including RSUs. This total reflects his position following the 16,493-share restricted stock unit award reported in the Form 4 filing.

At what price were Jeff Epstein’s new AvePoint (AVPT) RSUs valued?

The 16,493 restricted stock units were valued at $11.52 per share. This price is used in the Form 4 to describe the grant’s per-share value for the common stock underlying each RSU in the award.